Ligand Pharmaceuticals reported 84.31 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Amgen 18.07 1.77 Jun/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Arrowhead Research 39.19 2.48 Mar/2026
Baxter International 151.95 65.95 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Eli Lilly 32.9 7.37 Jun/2026
Enviri Corporation 121.21 92.59 Jun/2023
Gilead Sciences 13.51 4.2 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Glaxosmithkline 15.09 3.43 Mar/2026
Intrexon 7.54 221.44 Dec/2021
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ligand Pharmaceuticals 84.31 27.81 Jun/2026
Merck 32.26 15.74 Jun/2026
Pacira 35.68 2.9 Jun/2026
Pfizer 11.48 2.16 Jun/2026
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Veracyte 42.77 17.88 Jun/2026